LAS41004
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for LAS41004, covering 2011-10-31 to 2015-06-10. Get the full timeline:
Most recent: Clinical Trial Update: A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis [Phase 2]